Abstract:Objective: Invasive lung adenocarcinoma is composed of five different histological subgroups with diverse biological behavior and heterogeneous morphology, the acinar/papillary-predominant lung adenocarcinomas are the most common subgroups and recognized as an intermediate-grade group. In the real world, clinicians primarily consider predominant patterns and ignore the impact of minor components in the prognosis of lung adenocarcinoma. The study evaluated the clinicopathologic characteristics of the lepidic, solid, and micropapillary patterns as non-predominant components and whether the minimal patterns had prognostic value on acinar/papillary-predominant lung adenocarcinomas. Methods: A total of 153 acinar/papillary-predominant lung adenocarcinoma patients with tumor size ≤4 cm were classified into four risk subgroups based on the presence of lepidic and micropapillary/solid components: MP/S − Lep + , MP/S + Lep + , MP/S − Lep − , and MP/S + Lep − groups. The Cox-proportional hazard regression model was used to assess disease-free survival (DFS). Results: The risk subgroups based on the non-predominant patterns were associated with differentiation ( P = 0.001), lymphovascular invasion ( P = 0.001), and recurrence ( P = 0.003). In univariate analysis, DFS was correlated with non-predominant components ( P = 0.014), lymphovascular invasion ( P = 0.001), carcinoembryonic antigen (CEA) ( P = 0.001), and platelet-to-lymphocyte ratio (PLR) ( P = 0.012). In the multivariate analysis, non-predominant components ( P = 0.043) and PLR ( P = 0.032) were independent prognostic factors for DFS. The 5-year survival rates of MP/S − Lep + , MP/S + Lep + , MP/S − Lep − and MP/S + Lep − subgroups were 93.1%,92.9%,73.1%,61.9%, respectively. The MP/S − Lep + subgroup had the favorable prognosis than MP/S + Lep − subgroup with a statistically significant difference ( P = 0.002). As minor components, the lepidic patterns were a protective factor, and the solid and micropapillary components were poor factors. The recurrence was related to the presence of non-predominant patterns rather than their proportion. Adjuvant chemotherapy did not significantly improve the prognosis of the MP/S + Lep - subgroup ( P = 0.839). Conclusions: Regardless of the proportion, the presence of micropapillary/solid components and the absence of lepidic patterns are aggressive factors of DFS in patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.

Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma

Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern

Prognostic Impact of Non-Predominant Lepidic Components in Pathologic Stage I Invasive Nonmucinous Adenocarcinoma

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma

Pathological and Radiological T Descriptors in Invasive Lung Adenocarcinoma: from Correlations to Prognostic Significance.

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma

Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma

Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.

Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype

A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma

Identification of a Prognostic Classifier Based on EMT-related Lncrnas and the Function of LINC01138 in Tumor Progression for Lung Adenocarcinoma

Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I to IIIA LUAD

Characterization of TCF-1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients

Relationship Between PD-L1 Expression and Molecular Aberrances in Lung Adenocarcinoma with Solid Components

Multicenter Study for the Correlation among PD-L1 Antibodies, Tumor Mutation Burden (TMB) and Lung Immune Prognostic Index (lipi) in Chinese Patients with Advanced Lung Adenocarcinoma.

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma

Histopathologic Pattern and Molecular Risk Stratification Are Associated with Prognosis in Patients with Stage IB Lung Adenocarcinoma

Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma